Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Debouck

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|November 15, 1992
The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientationsK H Murthy, E L Winborne, M D Minnich, et al.
International Orthopaedics|August 3, 2001
Skeletal deformities induced by the intraperitoneal administration of deoxynivalenol (vomitoxin) in miceC Debouck, E Haubruge, P Bollaerts, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitroA Aldovini, C Debouck, M B Feinberg, et al.
The Journal of Clinical Investigation|June 1, 1992
Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120A Takeda, J E Robinson, D D Ho, et al.
Journal of Clinical Microbiology|May 1, 1989
Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genesV L Ng, C S Chiang, C Debouck, et al.
The Journal of Biological Chemistry|November 29, 1996
Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinaseS Kumar, M J Orsini, J C Lee, et al.
Biochemistry|December 7, 1993
Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitorsB Zhao, E Winborne, M D Minnich, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursorC Debouck, J G Gorniak, J E Strickler, et al.
AIDS (London, England)|April 1, 1989
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expressionP Reiss, A de Ronde, J M Lange, et al.
Proteins|January 1, 1989
Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coliJ E Strickler, J Gorniak, B Dayton, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|November 15, 1992
The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientationsK H Murthy, E L Winborne, M D Minnich, et al.
International Orthopaedics|August 3, 2001
Skeletal deformities induced by the intraperitoneal administration of deoxynivalenol (vomitoxin) in miceC Debouck, E Haubruge, P Bollaerts, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitroA Aldovini, C Debouck, M B Feinberg, et al.
The Journal of Clinical Investigation|June 1, 1992
Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120A Takeda, J E Robinson, D D Ho, et al.
Journal of Clinical Microbiology|May 1, 1989
Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genesV L Ng, C S Chiang, C Debouck, et al.
The Journal of Biological Chemistry|November 29, 1996
Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinaseS Kumar, M J Orsini, J C Lee, et al.
Biochemistry|December 7, 1993
Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitorsB Zhao, E Winborne, M D Minnich, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursorC Debouck, J G Gorniak, J E Strickler, et al.
AIDS (London, England)|April 1, 1989
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expressionP Reiss, A de Ronde, J M Lange, et al.
Proteins|January 1, 1989
Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coliJ E Strickler, J Gorniak, B Dayton, et al.
Pageof 8